Dr Jörg Täubel
Dr Jörg Täubel is Managing Director of Richmond Pharmacology. To date he has conducted more than 200 Phase I and early Phase IIa studies in patients and healthy volunteers, and been co-investigator for at least 150 more. His experience ranges from simple bioequivalence to complex pharmacokinetic and pharmacodynamic studies often administering compounds first in man. His particular interest is gastroenterology and bridging studies. Over the last 3 years, a large proportion of his work has been directly or indirectly related to these areas.
Dr Täubel has been a speaker at numerous conferences on various topics with an emphasis on pharmacology, bioequivalence studies and volunteer recruitment in particular and is the author of numerous publications in scientific journals.
Qualifications
| 1980–1987 | Medical School at the Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany. |
|---|---|
| 1987 | State Examination Medicine (German equivalent to the MB BS in the UK) and full registration as a Medical Practitioner (Approbation) awarded by the Hessisches Landesprüfungsamt für Heilberufe, Germany. |
| 1989 | MD (postgraduate), awarded by the University of Frankfurt, Germany. Title of Thesis: “Follow-up on 128 female and male patients one to two years after transluminal coronary angioplasty.” |
| 1999 | Member of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom. |
Clinical pharmacology experience
| From 2002 | Managing Director Richmond Pharmacology Ltd |
|---|---|
| 1995–2001 | Medical and Managing Director Charterhouse Clinical Research Unit Ltd |
| 1992–1995 | Medical Director Phase II – IV Charterhouse Clinical Research Unit Ltd |
| 1990–1992 | Research Physician Phase I AFB – PAREXEL, Arzneimittelforschung GmbH, Frankfurt & Berlin |
| 1987–1990 | Senior House Officer positions in various hospitals in the UK and Germany |
